Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 21-29 of 29

Page
per page
  1. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     5 Citation
    Target: p38
    Summary: P38 MAPK inhibitor
  2. LY2228820
    A5566 LY2228820
     1 Citation
    Target: p38
    Summary: P38 MAP kinase inhibitor
      ≥30.65 mg/mL
  3. BIRB 796 (Doramapimod)
    A5639 BIRB 796 (Doramapimod)
     1 Citation
    Summary: P38 MAPK inhibitor,cell permeable and highly selective
      ≥26.4 mg/mL
  4. BMS-582949
    B6187 BMS-582949
    Summary: p38 MAPK inhibitor
      Soluble in DMSO
  5. Pamapimod (R-1503, Ro4402257)
    B6188 Pamapimod (R-1503, Ro4402257)
    Summary: p38 MAPK inhibitor
      Soluble in DMSO
  6. SB 202474
    C4949 SB 202474
    Summary: a negative control in studies of p38 inhibition
      Soluble in methanol;Soluble in DMSO
  7. BMS-582949 hydrochloride
    B7850 BMS-582949 hydrochloride
    Summary: p38 MAPK inhibitor
      ≥44.3 mg/mL
  8. RWJ 67657
    C5316 RWJ 67657
    Summary: orally active inhibitor of the MAP kinases p38α and p38β
      ≤10 mg/mL
  9. Pexmetinib (ARRY-614)
    B6012 Pexmetinib (ARRY-614)
    Target: p38|Tie-2
    Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
      insoluble in H2O; ≥107.6 mg/mL

Items 21-29 of 29

Page
per page